← Open Payments lookup

ANJULI JINDAL: Open Payments

NPI 1043493372 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$904 in 35 payments from 9 companies in 2025. Trend: 2023 $158 · 2024 $503 · 2025 $904

Food & beverage: $904
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$295
Otsuka America Pharmaceutical, Inc.10$271
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$89
Alkermes, Inc.4$79
E.R. Squibb & Sons, L.L.C.2$46
Teva Pharmaceuticals USA, Inc.2$41
ABBVIE INC.2$33
Axsome Therapeutics, Inc.1$32
Vanda Pharmaceuticals Inc.1$18

Products named: INGREZZA, ABILIFY MAINTENA, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, REXULTI, COBENFY, UZEDY.

Industry payments across VA — which companies pay providers there.